Cora Elizabeth Ridenour

Cora Ridenour practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Cora Ridenour's NPI, 1750168076, was assigned on September 11, 2023. Cora Ridenour holds California license PA63295.

Cora Ridenour's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Cora Ridenour's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Gastroenterology Associates of Beverly Hills. Dmand AI also links Cora Ridenour to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Cora Ridenour practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Cora Ridenour's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Cora Ridenour is licensed in California.

CMS data shows 1,000 Medicare services from Cora Ridenour across 8 procedure codes in 2024, for 566 Medicare patients. Medicare paid $77,489 for them. Every service was in an office.

CMS counts 566 Medicare patients who saw Cora Ridenour in 2024. The largest group is 65 to 74, with 260 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Cora Ridenour's median patient age at 47, with 50% women.

In 2024, Cora Ridenour wrote 1,038 Medicare Part D claims for 383 patients. 76% of them were for generic drugs. CMS names the drug for 858 of them, across 15 drugs with 11 or more claims each, at $257,860 in total drug cost.

Cora Ridenour accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Cora Ridenour as offering telehealth.

CMS Open Payments shows 480 general payments to Cora Ridenour from 27 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 98% of the total. Bausch Health Americas, Inc. paid the most, $2,232.